Table 2.
Tumor Characteristics & Cancer Treatment
| Case (N, %) | Control (N, %) | |
|---|---|---|
| Gleason score | ||
| <7 | 19 (6%) | 123 (29%) |
| 7 | 157 (49%) | 188 (44%) |
| 8+ | 126 (39%) | 41 (10%) |
| Missing | 21 (6%) | 76 (17%) |
| P<0.0001 | ||
| Tumor grade | ||
| 1 | 4 (1%) | 7 (2%) |
| 2 | 37 (11%) | 153 (36%) |
| 3 | 282 (88%) | 262 (61%) |
| Missing | 0 (0%) | 6 (1%) |
| P<0.0001 | ||
| Positive Margins | ||
| Yes | 146 (45%) | 154 (36%) |
| No | 149 (46%) | 197 (46%) |
| Missing | 28 (9%) | 77 (18%) |
| P<0.0001 | ||
| Lymph nodes | ||
| Yes | 44 (14%) | 29 (7%) |
| No | 211 (65%) | 272 (64%) |
| Missing | 68 (21%) | 127 (29%) |
| P<0.0001 | ||
| PSA at diagnosis | ||
| 0–6 | 59 (18%) | 86 (20%) |
| 7–10 | 50 (15%) | 101 (24%) |
| 11–18 | 57 (18%) | 93 (22%) |
| 19+ | 77 (24%) | 70 (16%) |
| Missing | 80 (25%) | 78 (18%) |
| P=0.002 | ||
| Curative txt >6 months after diagnosis | ||
| Yes | 222 (69%) | 285 (67%) |
| No | 101 (31%) | 143 (33%) |
| P=0.73 | ||
| Radiation txt for curative intent plus prostatectomy | ||
| Yes | 99 (31%) | 65 (15%) |
| No | 224 (69%) | 363 (85%) |
| P<0.0001 | ||
| Neoadjuvant hormone treatment | ||
| Yes | 18 (6%) | 19 (4%) |
| No | 305 (94%) | 409 (96%) |
| P=0.48 | ||